Diffusion-weighted imaging was negative
As a result of the mounting scientific research linking GLP-1s to gastric illnesses and the tens of thousands adverse reports submitted to the FDA to date, the drug makers now face a growing number of Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits, each raising similar allegations that users were left with painful and debilitating stomach problems, which could have been avoided if false and misleading information had not been provided for users and the medical community
It reflects what you are not paying for at the cheap end: no provider involvement, no individualized dosing, no injection training, no sterile reconstitution guidance, and no recourse if you have a reaction
"There is a very, very strong biological basis for developing obesity." But that's not everyone
Mod Pathol 32(7):1053-1064, 2019
Off label uses have included such conditions as borderline personality disorder, and as an alternative choice to medications that induced unwanted side effects such as hyperprolactinemia, where breast enlargement and the production of breast milk in either males or females